InsidersTradesSigma
Follow the 셀트리온 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀트리온 has logged 469 reports. Market capitalisation: €43,824.4bn. The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: 셀트리온홀딩스. Every trade is accessible without an account.
461
Insider Decl.
n/a
Thresholds
€17m
189 ops.
Buy Volume
€68m
59 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 셀트리온 Buy (bullish), based on 23 analysts. Average price target: ₩266,032.
Fundamental score
Ranked 15,498 of 29,057 companies
50.2
score / 100
Value34
Quality67
FCF yld0.7%
Earn yld2.4%
EV/EBITDA30.9x
ROE9.1%
Gross mgn59%
Net mgn25%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations469 total
Other
Other
Other
Other
Other
Other
Other
Other
25 of 469 declarations
Acerca de 셀트리온
Celltrion es una empresa surcoreana centrada en el desarrollo y la fabricación de medicamentos biosimilares y terapias innovadoras. Cotiza en la Bolsa de Corea, XKRX.